Study for the Treatment of Significant Steatosis With Xenical Followed by Treatment of Hepatitis C With Pegasys/Copegus
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
This is a prospective, multi-center, randomized, placebo-controlled trial in subjects with
histological evidence of > 33% hepatic steatosis or nonalcoholic steatohepatitis (NASH) and
chronic hepatitis C. Patients who have not been previously treated for hepatitis C (treatment
naive) will be enrolled.